Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of 3-((1-(Benzyl(2-hydroxy-2-phenylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrazine-2-carboxylic Acid as a Potential Inhibitor of Non-Nucleosidase Reverse Transcriptase Inhibitors through InSilico Ligand- and Structure-Based Approaches.
Mathpal D, Almeleebia TM, Alshahrani KM, Alshahrani MY, Ahmad I, Asiri M, Kamal M, Jawaid T, Srivastava SP, Saeed M, Balaramnavar VM. Mathpal D, et al. Among authors: srivastava sp. Molecules. 2021 Aug 30;26(17):5262. doi: 10.3390/molecules26175262. Molecules. 2021. PMID: 34500699 Free PMC article.
Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking.
Balaramnavar VM, Srivastava R, Rahuja N, Gupta S, Rawat AK, Varshney S, Chandasana H, Chhonker YS, Doharey PK, Kumar S, Gautam S, Srivastava SP, Bhatta RS, Saxena JK, Gaikwad AN, Srivastava AK, Saxena AK. Balaramnavar VM, et al. Among authors: srivastava r, srivastava ak, srivastava sp. Eur J Med Chem. 2014 Nov 24;87:578-94. doi: 10.1016/j.ejmech.2014.09.097. Epub 2014 Oct 2. Eur J Med Chem. 2014. PMID: 25299681
Pharmacophore modeling, docking and the integrated use of a ligand- and structure-based virtual screening approach for novel DNA gyrase inhibitors: synthetic and biological evaluation studies.
Mathpal D, Masand M, Thomas A, Ahmad I, Saeed M, Zaman GS, Kamal M, Jawaid T, Sharma PK, Gupta MM, Kumar S, Srivastava SP, Balaramnavar VM. Mathpal D, et al. Among authors: srivastava sp. RSC Adv. 2021 Oct 25;11(55):34462-34478. doi: 10.1039/d1ra05630a. eCollection 2021 Oct 25. RSC Adv. 2021. PMID: 35494744 Free PMC article.
Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease.
Srivastava SP, Srivastava R, Chand S, Goodwin JE. Srivastava SP, et al. Among authors: srivastava r. Pharmaceuticals (Basel). 2021 Jul 30;14(8):751. doi: 10.3390/ph14080751. Pharmaceuticals (Basel). 2021. PMID: 34451848 Free PMC article. Review.
Cancer Biology and Prevention in Diabetes.
Srivastava SP, Goodwin JE. Srivastava SP, et al. Cells. 2020 Jun 2;9(6):1380. doi: 10.3390/cells9061380. Cells. 2020. PMID: 32498358 Free PMC article. Review.
Editorial: Combating Diabetes and Diabetic Kidney Disease.
Srivastava SP, Kanasaki K, Goodwin JE. Srivastava SP, et al. Front Pharmacol. 2021 Jul 8;12:716029. doi: 10.3389/fphar.2021.716029. eCollection 2021. Front Pharmacol. 2021. PMID: 34305620 Free PMC article. No abstract available.
Loss of Mitochondrial Control Impacts Renal Health.
Srivastava SP, Kanasaki K, Goodwin JE. Srivastava SP, et al. Front Pharmacol. 2020 Dec 9;11:543973. doi: 10.3389/fphar.2020.543973. eCollection 2020. Front Pharmacol. 2020. PMID: 33362536 Free PMC article. Review.
Editorial: Receptor Biology and Cell Signaling in Diabetes.
Srivastava SP, Kanasaki K. Srivastava SP, et al. Front Pharmacol. 2022 Mar 16;13:864117. doi: 10.3389/fphar.2022.864117. eCollection 2022. Front Pharmacol. 2022. PMID: 35370643 Free PMC article. No abstract available.
243 results